Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Westlake Therapeutics
company
About
The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.
- Hangzhou,Zhejiang,China
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- ¥100M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Product Research
- Founded date
- Jan 1, 2019
- Operating Status
- Active
- Legal Name
- West Biomedical Technology (Hangzhou) Co., Ltd.
- Also Known As
- West Lake Biopharmaceuticals,West Biomedical Technology (Hangzhou) Co., Ltd.,West Biomedicine
Q1 2022 c-suite not found.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥100M
Westlake Therapeutics has raised a total of
¥100M
in funding over 2 rounds. Their latest funding was raised on
Jul 15, 2021 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 15, 2021 | Series Unknown | ¥100M | 4 |
Sequoia Capital China
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
4
Westlake Therapeutics is funded by 4 investors.
Sequoia Capital China
and Stow Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Sequoia Capital China
|
Yes | Series Unknown |
|
|
— | Series Unknown |
CD Capital
|
— | Series Unknown |
Fang Group
|
— | Series Unknown |
Employee Profiles
Number of Employee Profiles
1
Westlake Therapeutics has 1 current employee profiles, including
Executive Xiaofei Gao
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
